Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore

Neurology

Volumn 80, Issue 17, 2013, Pages 1621-1622

  Dong, Di ^a   Sung, Cynthia ^a   Finkelstein, Andrew ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; HLA B ANTIGEN; PHENYTOIN; HLA B15 ANTIGEN; ANTICONVULSIVE AGENT; CHOLINESTERASE INHIBITOR;

BLINDNESS; COST EFFECTIVENESS ANALYSIS; DRY EYE; GENETIC RISK; HEALTH CARE COST; HEREDITY; HUMAN; KERATOPROSTHESIS; LETTER; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SINGAPORE; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; DECISION MAKING; ECONOMICS; EPILEPSY; FEMALE; GENETIC SCREENING; GENETICS; MALE; NOTE; COGNITION; DEMENTIA; EYE DISEASE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HOSPITAL DISCHARGE;

DECISION MAKING; EPILEPSY; FEMALE; GENETIC TESTING; HLA-B15 ANTIGEN; HUMANS; MALE;

EID: 84878932808     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182915be2     Document Type: Letter

References (5)

1. *1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore. Neurology 2012;79:1259-1267.
2. Hung SI, Chung WH, Jee SH, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics 2006;16:297-306.
3. Hung SI, Chung WH, Liu ZS, et al. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 2010;11:349-356.
4. *1502 allele in Thai population. Epilepsia 2008;49:2087-2091.
5. Yang CY, Dao RL, Lee TJ, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 2011;77:2025-2033.